Cytodrox 500MG Capsule is a pharmaceutical product containing Hydroxyurea as its active ingredient, with each capsule delivering a potent dose of 500 mg. This medication is primarily utilized in the treatment of certain types of cancer, including chronic myeloid leukemia and head and neck cancers, as well as in managing sickle cell disease. Hydroxyurea works by inhibiting the synthesis of DNA, thereby slowing down the growth of cancer cells and reducing the frequency of painful crises in sickle cell patients. The formulation is designed for oral administration, making it convenient for patients. Cytodrox is often prescribed as part of a comprehensive treatment plan, and its effectiveness is supported by clinical studies. Patients should be aware of the importance of adhering to prescribed dosages and monitoring for potential side effects, ensuring optimal therapeutic outcomes.